Global Recombinant Cell Culture Supplements Market

Global Recombinant Cell Culture Supplements Market: Focus on Recombinant Supplement Products, Applications, and Region – Analysis and Forecast: 2018 to 2028

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.

SKU: BH074A
Published Year: 2018
PLEASE SELECT A LICENSE TYPE
 
 
 

The process of cell culture involves the growth or proliferation of cells extracted from plant or animal sources under controlled conditions in an artificial media. Cell culture is an integral part of biotechnology and finds usage in various applications both commercial and research. Cell culture studies are now employed in the field of genetics, cell therapy, and regenerative medicine, among others. Culturing of cells under laboratory condition allows to study both physiology and biochemistry of cells, which further offers research scopes that are difficult to conduct in-vivo. The effects of drugs or other compounds can easily be tested on cultured cells by controlling parameters such as culture medium, culture conditions, population density, and growth rate. Furthermore, it offers huge prospects in the field of genetics and allows investigating the role of different genes.

Defined supplements in the cell culture media has shown promising impact since decades, aiding in the growth and productivity and maintaining the consistency of cultured cells. With the rise in the demand for cell culture optimization projects, there is a paradigm shift toward the increased application of defined, animal-free supplements for biopharmaceutical, vaccine, and stem cell manufacturing. Recombinant proteins serve as defined supplements in the cell culture media that boost the growth, productivity, and consistency of cultured cells. The use of these supplements acted as a major driving factor toward the adoption of serum-free media for culturing cells and development of cell-lines. The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors include rising investment in the R&D of life sciences and increasing demand for cell culture supplements.

The global recombinant cell culture supplements market is segmented based on products into various recombinant products, such as recombinant insulin, recombinant transferrin, recombinant trypsin, recombinant albumin, recombinant aprotinin, and recombinant epidermal growth factor, among others. On the basis of the application of these recombinant supplement products, the market can be segmented into stem cells and regenerative medicine, bioproduction, and academics and research. The market analysis includes an in-depth examination of the key ecosystem players, key strategies, and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges) and industry analysis. Geographically, the market can be segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

The purpose of the study is to gain a holistic view of the global recombinant cell culture supplements market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market and scientific innovations with respect to product evolution. The scope of the report is centred upon conducting a detailed study of the solutions allied with recombinant cell culture supplements market, which involves wide range of products used in biotechnological applications. The recombinant cell culture supplements market is segmented into three different parts: ‘by products’, ‘by application, and ‘by region’. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global recombinant cell culture supplements market and assesses the factors governing the same. Detailed product mapping have been included in the report. The market (by region) has been further sub-segmented in various countries, and in each sub-segment the key market trends, list of the key players, and recent developments have been discussed.

The answers to the following key questions can be derived from this report:

•    What are the major market drivers, restraints, and opportunities in the global recombinant cell culture supplements market?
•    What were the market shares of the leading segments and sub-segments of the global recombinant cell culture supplements market in 2017, and what will be the share in 2028 
•    How will each segment of the global recombinant cell culture supplements market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
•    What are the influencing factors that may affect the market share of the key players?
•    What are the key developmental strategies implemented by the key players to stand out in this market?
•    What are the major regulatory authorities/associations/consortiums affecting the global recombinant cell culture supplements market?
•    What are the types of recombinant cell culture supplement products in market and what are their market shares?
•    In 2017, which recombinant supplement type was the dominant type in the market in terms of revenue?
•    Which recombinant supplement type is expected to have the highest CAGR during the forecast period?
•    How has the market been segmented based on application? In 2017, which application area had the largest share and the fastest growth rate in the global recombinant cell culture supplements market?
•    Which geographical region will contribute to the highest sales of the recombinant cell culture supplements during the forecast period, and which will have the highest CAGR?

The report also profiles 17 companies including several key players, such as Thermo Fisher Scientific, Hi-Media Laboratories, BBI Solutions, PeproTech, Inc., InVitria, Sino Biologicals, STEMCELL Technologies, Irvine Scientific, Merck KGaA, Corning Incorporated, Gemini Bio-Products, Novozyme A/S, and Repligen Corporation, among others.

    Executive Summary
    1    Market Overview
          1.1    Fundamentals of Cell Culture
          1.2    Role of Media and Supplements
          1.3    Serum-free Media vs. Serum containing Media
          1.4    Technological Advancements of Defined Media and Importance of Recombinant Cell Culture Supplements
          1.5    Recombinant Cell Culture Supplements Market Scenario
          1.6    Assumptions and Limitations for Market Size Calculations
 
    2    Market Dynamics
          2.1    Market Drivers
                   2.1.1    Benefits of Using Recombinant Cell Culture Supplements
                   2.1.2    Increase in Funding and Investment in R&D of Life Science Sector
                   2.1.3    Rising Demand for Advanced Cell Culture Products
          2.2    Market Restraints
                   2.2.1    High Cost of Cell Biology Research
                   2.2.2    Technical Considerations Associated with Cell Culture
                   2.2.3    Lack of Infrastructure and Skilled Professionals for Cell-based Research
          2.3    Market Opportunities
                   2.3.1    Rising Demand for Monoclonal Antibodies and Stem Cell Research
                   2.3.2    Increasing Preference for Serum-Free Media
 
    3    Industry Insights
          3.1    Regulatory Scenario
          3.2    Patent Landscape
 
    4    Competitive Landscape
          4.1    Key Developmental Strategies
                   4.1.1    Product Launch
                   4.1.2    Agreement, Collaboration, and Partnership
                   4.1.3    Acquisition
                   4.1.4    Business Expansion
                   4.1.5    Others
          4.2    Market Share Analysis
 
    5    Global Recombinant Cell Culture Supplements Market (by Products)
          5.1    Overview
          5.2    Supplements
                   5.2.1    Recombinant Albumin (rAlbumin)
                   5.2.2    Recombinant Insulin (rInsulin)
                   5.2.3    Recombinant Epidermal Growth Factor (rEGF)
                   5.2.4    Recombinant Transferrin (rTransferrin)
                   5.2.5    Recombinant Trypsin (rTrypsin)
                   5.2.6    Recombinant Insulin-like Growth Factor (rIGF)
                   5.2.7    Recombinant Stem Cell Factor (SCF) Protein (rSCF)
                   5.2.8    Recombinant Aprotinin (rAprotinin)
                   5.2.9    Recombinant Lysozyme (rLysozyme)
                   5.2.10   Others
 
    6    Global Recombinant Cell Culture Supplements Market (by Application)
          6.1    Overview
          6.2    Stem Cell and Regenerative Medicine
          6.3    BioProduction
          6.4    Academic and Research Application
 
    7    Global Recombinant Cell Culture Supplements Market (by Region)
          7.1    Overview
          7.2    North America
                   7.2.1    The U.S.
                   7.2.2    Canada
          7.3    Europe
                   7.3.1    Germany
                   7.3.2    France
                   7.3.3    The U.K.
                   7.3.4    Italy
                   7.3.5    Spain
                   7.3.6    The Netherlands
                   7.3.7    Rest-of-Europe
          7.4    Asia-Pacific
                   7.4.1    China
                   7.4.2    Japan
                   7.4.3    S. Korea
                   7.4.4    India
                   7.4.5    Australia
                   7.4.6    Rest-of-Asia-Pacific
          7.5    Latin-America
                   7.5.1    Brazil
                   7.5.2    Mexico
                   7.5.3    Rest-of-Latin America
          7.6    Rest of the World (RoW)
                   7.6.1    Russia
                   7.6.2    Israel
                   7.6.3    Kingdom of Saudi Arabia (K.S.A.)
                   7.6.4    Others
 
    8    Company Profiles
          8.1    BBI Solutions
                   8.1.1    Company Overview
                   8.1.2    Role of BBI Solutions in the Recombinant Cell Culture Supplements Market
                   8.1.3    SWOT Analysis
          8.2    Corning Incorporated
                    8.2.1    Company Overview
                    8.2.2    Role of Corning Incorporated in Recombinant Cell Culture Supplements Market
                    8.2.3    Financials
                    8.2.4    Key Insights on Financial Health of the Company
                    8.2.5    Global Presence
                    8.2.6    SWOT Analysis
           8.3    Evercyte GmbH
                    8.3.1    Company Overview
                    8.3.2    Role of Evercyte GmbH in Recombinant Cell Culture Supplements Market
                    8.3.3    SWOT Analysis
           8.4    Gemini Bio-Products
                    8.4.1    Company Overview
                    8.4.2    Role of Gemini Bio-Products in Recombinant Cell Culture Supplements Market
                    8.4.3    SWOT Analysis
           8.5    HiMedia Laboratories
                    8.5.1    Company Overview
                    8.5.2    Role of HiMedia Laboratories in Recombinant Cell Culture Supplements Market
                    8.5.3    SWOT Analysis
           8.6    InVitria
                    8.6.1    Company Overview
                    8.6.2    Role of InVitria in the Recombinant Cell Culture Supplements Market
                    8.6.3    SWOT Analysis
           8.7    Irvine Scientific
                    8.7.1    Company Overview
                    8.7.2    Role of Irvine Scientific in Global Recombinant Cell Culture Supplements Market
                    8.7.3    SWOT Analysis
           8.8    Kingfisher Biotech, Inc.
                    8.8.1    Company Overview
                    8.8.2    Role of Kingfisher Biotech, Inc. in Recombinant Cell Culture Supplements Market
                    8.8.3    SWOT Analysis
           8.9    Lonza Group
                    8.9.1    Company Overview
                    8.9.2    Role of Lonza in Recombinant Cell Culture Supplements Market
                    8.9.3    Financials
                    8.9.4    Key Insights on Financial Health of the Company
                    8.9.5    Global Presence
                    8.9.6    SWOT Analysis
          8.10   Merck KGaA
                    8.10.1    Company Overview
                    8.10.2    Role of Merck KGaA in Recombinant Cell Culture Supplements Market
                    8.10.3    Financials
                    8.10.4    Key Insights on the Financial Health of Company
                    8.10.5    Global Presence
                    8.10.6    SWOT Analysis
          8.11   Novozymes
                    8.11.1    Company Overview
                    8.11.2    Role of Novozymes in Recombinant Cell Culture Supplements Market
                    8.11.3    Financials
                    8.11.4    Key Insights on Financial Health of the Company
                    8.11.5    Global Presence
                    8.11.6    SWOT Analysis
          8.12   PeproTech, Inc.
                    8.12.1    Company Overview
                    8.12.2    Role of PeproTech, Inc. in the Recombinant Cell Culture Supplements Market
                    8.12.3    SWOT Analysis
          8.13   Repligen Corporation
                    8.13.1    Company Overview
                    8.13.2    Role of Repligen Corporation in the Recombinant Cell Culture Supplements Market
                    8.13.3    Financials
                    8.13.4    Key Insights on Financial Health of the Company
                    8.13.5    Global Presence
                    8.13.6    SWOT Analysis
          8.14   Shenandoah Biotechnology
                    8.14.1    Company Overview
                    8.14.2    Role of Shenandoah Biotechnology in the Recombinant Cell Culture Supplements Market
                    8.14.3    SWOT Analysis
          8.15   Sino Biological Inc.
                    8.15.1    Company Overview
                    8.15.2    Role of Sino Biological Inc. in the Recombinant Cell Culture Supplements Market
                    8.15.3    SWOT Analysis
          8.16   STEMCELL Technologies Inc.
                    8.16.1    Company Overview
                    8.16.2    Role of STEMCELL Technologies Inc. in the Recombinant Cell Culture Supplements Market
                    8.16.3    SWOT Analysis
          8.17   Thermo Fisher Scientific
                    8.17.1    Company Overview
                    8.17.2    Role of Thermo Fisher Scientific in the Recombinant Cell Culture Supplements Market
                    8.17.3    Financials
                    8.17.4    Key Insights on the Financial Health of the Company
                    8.17.5    Global Presence
                    8.17.6    SWOT Analysis
          8.18   Albumedix: Snapshot
                    8.18.1    Company Overview
                    8.18.2    Product Portfolio
 
    9    Research Scope and Methodology
          9.1    Scope of the Report
          9.2    Global Recombinant Cell Culture Supplements Market Segmentation
          9.3    Research Methodology
                   9.3.1    Primary Research
                   9.3.2    Secondary Research
                   9.3.3    Key Data Points from Primary and Secondary Sources
                   9.3.4    Data Triangulation
                   9.3.5    Top-Down Approach
                   9.3.6    Bottom- Up Approach
          9.4    Assumptions and Limitations
 

List of Tables

Table 1.1    Recombinant Cell-Culture Supplements Product Offerings of Some Key Companies
Table 2.1    Impact Analysis of Market Dynamics
Table 3.1    Global Regulatory Scenario
Table 3.2    Patents Granted between January 2015 and March 2018
Table 5.1    Recombinant Albumin Products
Table 5.2    Global Recombinant Albumin Market (by Application), 2017-2028, $Million
Table 5.3    Global Recombinant Insulin Market (by Application), 2017-2028, $Million
Table 5.4    Recombinant EGF Products
Table 5.5    Global Recombinant EGF Market (by Application), 2017-2028, $Million
Table 5.6    Recombinant Transferrin Products
Table 5.7    Global Recombinant Transferrin Market (by Application), 2017-2028, $Million
Table 5.8    Recombinant Trypsin Products
Table 5.9    Global Recombinant Trypsin Market (by Application), 2017-2028, $Million
Table 5.10    Recombinant IGF-I Products
Table 5.11    Global Recombinant IGF-I Market (by Application), 2017-2028, $Million
Table 5.12    Global Recombinant SCF Supplement Products
Table 5.13    Global Recombinant SCF Market (by Application), 2017-2028, $Million
Table 5.14    Recombinant Aprotinin Products
Table 5.15    Global Recombinant Aprotinin Market (by Application), 2017-2028, $Million
Table 5.16    Recombinant Lysozyme Products
Table 5.17    Global Recombinant Lysozyme Market (by Application), 2017-2028, $Million
Table 5.18    Global Recombinant Others Supplement Products
Table 5.19    Global Recombinant Others Supplements Market (by Application), 2017-2028, $Million
Table 6.1    Companies along with Biomanufacturing Facility
Table 7.1    Global Recombinant Cell Culture Supplements Market (by Region), 2017-2028, $Million
Table 7.2    North America Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.3    Europe Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.4    Asia-Pacific Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.5    Latin America Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.6    RoW Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million

List of Figures

Figure 1    Global Recombinant Cell Culture Supplements Market, 2017-2028
Figure 2    Global Recombinant Cell Culture Supplements Market (by Product), 2017 and 2028
Figure 3    Global Recombinant Cell Culture Supplements Market (by Application), 2017 and 2028
Figure 4    Global Recombinant Cell Culture Supplements Market (by Region), 2017 and 2028
Figure 1.1    Important Terminology of Cell Culture Procedure
Figure 1.2    Market for Global Recombinant Cell Culture Supplements
Figure 1.3    Global Recombinant Cell Culture Supplements Market, 2017-2028
Figure 1.4    Recombinant Cell Culture Supplements Market Segmentation
Figure 4.1    Share of Key Developmental Strategies, January 2015-July 2018
Figure 4.2    Share of Product Launch (by Company), January 2015-July 2018
Figure 4.3    Share of Agreement, Collaboration, and Partnership (by Company), January 2015-July 2018
Figure 4.4    Share of Acquisition (by Company), January 2015-July 2018
Figure 4.5    Share of Business Expansion (by Company), January 2015-July 2018
Figure 4.6    Share of Other Developments (by Company), January 2015-July 2018
Figure 4.7    Global Recombinant Cell Culture Supplements Market Share of Key Players, 2017 and 2018
Figure 4.8    Growth Share Matrix, (by Company)2018
Figure 5.1    Different Types of Cell Culture Products
Figure 5.2    Global Recombinant Cell Culture Supplements Market (by Product), 2017-2028
Figure 5.3    Global Recombinant Albumin Market, 2017-2028
Figure 5.4    Global Recombinant Insulin Market, 2017-2028
Figure 5.5    Global Recombinant EGF Market, 2017-2028
Figure 5.6    Global Recombinant Transferrin Market, 2017-2028
Figure 5.7    Features of Recombinant Trypsin
Figure 5.8    Global Recombinant Trypsin Market, 2017-2028
Figure 5.9    Global Recombinant IGF-I Market, 2017-2028
Figure 5.10    Global Recombinant SCF Market, 2017-2028
Figure 5.11    Global Recombinant Aprotinin Market, 2017-2028
Figure 5.12    Global Recombinant Lysozyme Market, 2017-2028
Figure 5.13    Global Recombinant Other Supplements Market, 2017-2028
Figure 6.1    Global Recombinant Cell Culture Supplements (by Application)
Figure 6.2    Global Recombinant Cell Culture Supplements (by Application), 2017-2028
Figure 6.3    Regenerative Medicine: Present and Future
Figure 6.4    Types of Stem Cells
Figure 6.5    Global Recombinant Cell Culture Supplements Market (by Stem Cells and Regenerative Medicine), 2017-2028
Figure 6.6    Global Recombinant Cell Culture Supplements Market (by Bioproduction), 2017-2028
Figure 6.7    Global Recombinant Cell Culture Supplements Market (by Academic and Research), 2017-2028
Figure 7.1    Global Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.2    North America Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.3    North America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.4    U.S. Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.5    Canada Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.6    Europe Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.7    Europe Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.8    Germany Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.9    France Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.10    The U.K. Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.11    Italy Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.12    Spain Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.13    The Netherlands Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.14    Rest-of-Europe Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.15    Asia-Pacific Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.16    Asia-Pacific Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.17    China Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.18    Japan Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.19    S.Korea Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.20    India Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.21    Australia Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.22    Rest-of-Asia-Pacific Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.23    Latin America Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.24    Latin America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.25    Brazil Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.26    Mexico Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.27    Rest-of-Latin-America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.28    RoW Recombinant Cell Culture Supplements Market 2017-2028
Figure 7.29    RoW Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.30    Russia Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.31    Israel Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.32    K.S.A. Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.33    Others Recombinant Cell Culture Supplements Market, 2017-2028
Figure 8.1    Contribution of Public and Private Company Profiles
Figure 8.2    BBI Solutions: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.3    BBI Solutions: SWOT Analysis
Figure 8.4    Corning Incorporated: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.5    Corning Incorporated: Overall Financials, 2015-2017
Figure 8.6    Corning Incorporated: Revenue (by Business Segment), 2015-2017
Figure 8.7    Corning Incorporated: Revenue (by Region), 2015-2017
Figure 8.8    Corning Incorporated: R&D Expense, 2015-2017
Figure 8.9    Corning Incorporated: Revenue Forecast, 2015-2020
Figure 8.10    Corning Incorporated: Global Presence
Figure 8.11    Corning Incorporated: SWOT Analysis
Figure 8.12    Evercyte GmbH: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.13    Evercyte GmbH: SWOT Analysis
Figure 8.14    Gemini Bio-Products Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.15    Gemini Bio-Products: SWOT Analysis
Figure 8.16    HiMedia Laboratories: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.17    Himedia Laboratories: SWOT Analysis
Figure 8.18    InVitria: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.19    InVitria: SWOT Analysis
Figure 8.20    Irvine Scientific: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.21    Irvine Scientific: SWOT Analysis
Figure 8.22    Kingfisher Biotech, Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.23    Kingfisher Biotech, Inc.: SWOT Analysis
Figure 8.24    Lonza Group: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.25    Lonza Group: Overall Financials, 2015-2017
Figure 8.26    Lonza Group: Revenue (by Business Segment), 2015-2017
Figure 8.27    Lonza Group: Revenue (by Region), 2015-2017
Figure 8.28    Lonza Group: R&D Expense, 2015-2017
Figure 8.29    Lonza Group: Revenue Forecast, 2015-2020
Figure 8.30    Lonza Group: Global Presence
Figure 8.31    Lonza Group: SWOT Analysis
Figure 8.32    Merck KGaA: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.33    Merck KGaA: Overall Financials, 2015-2017
Figure 8.34    Merck KGaA: Revenue (by Business Segment), 2015-2017
Figure 8.35    Merck KGaA: Revenue (by Region), 2015-2017
Figure 8.36    Merck KGaA: R&D Expense, 2015-2017
Figure 8.37    Merck KGaA: Revenue Forecast, 2015-2020
Figure 8.38    Merck KGaA: Global Presence
Figure 8.39    Merck KGaA: SWOT Analysis
Figure 8.40    Novozymes: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.41    Novozymes: Overall Financials, 2015-2017
Figure 8.42    Novozymes: Revenue (by Business Segment), 2015-2017
Figure 8.43    Novozymes: Revenue (by Region), 2015-2017
Figure 8.44    Novozymes: R&D Expense, 2015-2017
Figure 8.45    Novozymes: Revenue Forecast, 2015-2020
Figure 8.46    Novozymes: Global Presence
Figure 8.47    Novozymes: SWOT Analysis
Figure 8.48    PeproTech, Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.49    PeproTech, Inc.: Recombinant Proteins for Cell Culture under Growth Factor and Cytokines Segment
Figure 8.50    PeproTech, Inch: SWOT Analysis
Figure 8.51    Repligen: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.52    Repligen Corporation: Overall Financials, 2015-2017
Figure 8.53    Repligen Corporation: Revenue (by Business Segment), 2015-2017
Figure 8.54    Repligen Corporation: Revenue (by Geography), 2015-2017
Figure 8.55    Repligen Corporation: R&D Expense, 2015-2017
Figure 8.56    Repligen Corporation: Revenue Forecast, 2015-2020
Figure 8.57    Repligen Corporation: Global Presence
Figure 8.58    Repligen Corporation: SWOT Analysis
Figure 8.59    Shenandoah Biotechnology Inc Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.60    Shenandoah Biotechnology Inc: SWOT Analysis
Figure 8.61    Sino Biological Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.62    Sino Biological Inc.: SWOT Analysis
Figure 8.63    STEMCELL Technologies Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.64    STEMCELL Technologies Inc.: SWOT Analysis
Figure 8.65    Thermo Fisher Scientific: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.66    Thermo Fisher Scientific: Overall Financials, 2015-2017
Figure 8.67    Thermo Fisher Scientific: Revenue (by Business Segment), 2015-2017
Figure 8.68    Thermo Fisher Scientific: Revenue (by Region), 2015-2017
Figure 8.69    Thermo Fisher Scientific: R&D Expense, 2015-2017
Figure 8.70    Thermo Fisher Scientific: Revenue Forecast, 2015-2020
Figure 8.71    Thermo Fisher Scientific: Global Presence
Figure 8.72    Thermo Fisher Scientific: SWOT Analysis
Figure 8.73    Albumedix: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 9.1    Global Recombinant Cell Culture Supplements Market Segmentation
Figure 9.2    Research Methodology
Figure 9.3    Key Data Points from Primary and Secondary Sources
Figure 9.4    Data Triangulation
Figure 9.5    Top-down Approach: Global Recombinant Cell Culture Supplements Market
Figure 9.6    Bottom-up Approach: Global Recombinant Cell Culture Supplements Market
Figure 9.7    Assumptions and Limitations

With advancement in technology, techniques, and methodology, several innovative products are developed and commercialized by various industries into the market. Development in biotech and healthcare industries has led to the emergence of modern day cell culture process and techniques. Cell cultures are currently used for various applications such as bioproduction of vaccines, monoclonal antibodies, and proteins, among others. Also, research and developmental activities have increased the usage of cell culture techniques for the genetic engineering, genomics, and therapeutic research. Cell culture involves different types of products for the growth of cells such as media, sera, reagents, and supplements. Supplements help in the growth of the cell lines and culture.

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028. The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors supporting the growth of the market include increasing investment in the R&D of life sciences and biotechnology industries.

The purpose of the study is to gain a holistic view of the global recombinant cell culture supplements market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market, and scientific innovations into biotechnology and cell culture fields. The scope of the report is centered upon conducting a detailed study of the solutions allied with the recombinant cell culture supplements market, involving products used for different applications such as bioproduction, research and academics, and stem cell and regenerative medicine. The global recombinant cell culture supplements market is segmented into three different parts: by products, by application, and by region.

Based on applications, the market can be sub-segmented into stem cell and regenerative medicine, bioproduction, and academic and research. In 2017, stem cell and regenerative medicine was estimated to be the dominant application segment due to the increased demand for investment in the stem cell and regenerative medicine industry in developed as well as developing nations. However, the academic and research industry is expected to register the highest CAGR due to the rising investments and increased regulatory support for this industry. As recombinant supplements ensure enhanced cell viability and improved batch-to-batch consistency, they are increasingly used for research.

The recombinant cell culture supplements market can be further segmented based on the type of recombinant products into transferrin, insulin, albumin, trypsin, aprotinin, lysozyme, Insulin-like growth factor, stem cell factor, epidermal growth factor, and others. Recombinant albumin was the dominant segment in terms of revenue in 2017 while recombinant epidermal growth factor (rEGF) segment is expected to be the fastest growing segment during the forecast period from 2018 to 2028.

Geographically, the market is segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World. North America, followed by Europe, is the leading contributor of the market. Within North America, the U.S. contributed to almost 93% of the total share, and the rest of the share was occupied by Canada in 2017. Within Europe, Germany dominated the market in 2017. However, the market for the Asia-Pacific region is expected to witness the high growth rate, during the forecast period from 2018 to 2028, as compared to other regions.

The recombinant cell culture supplements market has a promising potential for the growth in the coming years with the increased usage of cell cultures and biotechnology in the modern day science. The report provides an in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each company. The key players of the market are Thermo Fisher Scientific, Hi-Media Laboratories, BBI Solutions, PeproTech, Inc., InVitria, Sino Biologicals, STEMCELL Technologies, Irvine Scientific, Merck KGaA, Corning Incoporated, Gemini Bio-Products, Novozyme A/S, and Repligen Corporation, among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields
 

The process of cell culture involves the growth or proliferation of cells extracted from plant or animal sources under controlled conditions in an artificial media. Cell culture is an integral part of biotechnology and finds usage in various applications both commercial and research. Cell culture studies are now employed in the field of genetics, cell therapy, and regenerative medicine, among others. Culturing of cells under laboratory condition allows to study both physiology and biochemistry of cells, which further offers research scopes that are difficult to conduct in-vivo. The effects of drugs or other compounds can easily be tested on cultured cells by controlling parameters such as culture medium, culture conditions, population density, and growth rate. Furthermore, it offers huge prospects in the field of genetics and allows investigating the role of different genes.

Defined supplements in the cell culture media has shown promising impact since decades, aiding in the growth and productivity and maintaining the consistency of cultured cells. With the rise in the demand for cell culture optimization projects, there is a paradigm shift toward the increased application of defined, animal-free supplements for biopharmaceutical, vaccine, and stem cell manufacturing. Recombinant proteins serve as defined supplements in the cell culture media that boost the growth, productivity, and consistency of cultured cells. The use of these supplements acted as a major driving factor toward the adoption of serum-free media for culturing cells and development of cell-lines. The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors include rising investment in the R&D of life sciences and increasing demand for cell culture supplements.

The global recombinant cell culture supplements market is segmented based on products into various recombinant products, such as recombinant insulin, recombinant transferrin, recombinant trypsin, recombinant albumin, recombinant aprotinin, and recombinant epidermal growth factor, among others. On the basis of the application of these recombinant supplement products, the market can be segmented into stem cells and regenerative medicine, bioproduction, and academics and research. The market analysis includes an in-depth examination of the key ecosystem players, key strategies, and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges) and industry analysis. Geographically, the market can be segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

The purpose of the study is to gain a holistic view of the global recombinant cell culture supplements market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market and scientific innovations with respect to product evolution. The scope of the report is centred upon conducting a detailed study of the solutions allied with recombinant cell culture supplements market, which involves wide range of products used in biotechnological applications. The recombinant cell culture supplements market is segmented into three different parts: ‘by products’, ‘by application, and ‘by region’. The report offers the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering questions related to various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global recombinant cell culture supplements market and assesses the factors governing the same. Detailed product mapping have been included in the report. The market (by region) has been further sub-segmented in various countries, and in each sub-segment the key market trends, list of the key players, and recent developments have been discussed.

The answers to the following key questions can be derived from this report:

•    What are the major market drivers, restraints, and opportunities in the global recombinant cell culture supplements market?
•    What were the market shares of the leading segments and sub-segments of the global recombinant cell culture supplements market in 2017, and what will be the share in 2028 
•    How will each segment of the global recombinant cell culture supplements market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
•    What are the influencing factors that may affect the market share of the key players?
•    What are the key developmental strategies implemented by the key players to stand out in this market?
•    What are the major regulatory authorities/associations/consortiums affecting the global recombinant cell culture supplements market?
•    What are the types of recombinant cell culture supplement products in market and what are their market shares?
•    In 2017, which recombinant supplement type was the dominant type in the market in terms of revenue?
•    Which recombinant supplement type is expected to have the highest CAGR during the forecast period?
•    How has the market been segmented based on application? In 2017, which application area had the largest share and the fastest growth rate in the global recombinant cell culture supplements market?
•    Which geographical region will contribute to the highest sales of the recombinant cell culture supplements during the forecast period, and which will have the highest CAGR?

The report also profiles 17 companies including several key players, such as Thermo Fisher Scientific, Hi-Media Laboratories, BBI Solutions, PeproTech, Inc., InVitria, Sino Biologicals, STEMCELL Technologies, Irvine Scientific, Merck KGaA, Corning Incorporated, Gemini Bio-Products, Novozyme A/S, and Repligen Corporation, among others.

    Executive Summary
    1    Market Overview
          1.1    Fundamentals of Cell Culture
          1.2    Role of Media and Supplements
          1.3    Serum-free Media vs. Serum containing Media
          1.4    Technological Advancements of Defined Media and Importance of Recombinant Cell Culture Supplements
          1.5    Recombinant Cell Culture Supplements Market Scenario
          1.6    Assumptions and Limitations for Market Size Calculations
 
    2    Market Dynamics
          2.1    Market Drivers
                   2.1.1    Benefits of Using Recombinant Cell Culture Supplements
                   2.1.2    Increase in Funding and Investment in R&D of Life Science Sector
                   2.1.3    Rising Demand for Advanced Cell Culture Products
          2.2    Market Restraints
                   2.2.1    High Cost of Cell Biology Research
                   2.2.2    Technical Considerations Associated with Cell Culture
                   2.2.3    Lack of Infrastructure and Skilled Professionals for Cell-based Research
          2.3    Market Opportunities
                   2.3.1    Rising Demand for Monoclonal Antibodies and Stem Cell Research
                   2.3.2    Increasing Preference for Serum-Free Media
 
    3    Industry Insights
          3.1    Regulatory Scenario
          3.2    Patent Landscape
 
    4    Competitive Landscape
          4.1    Key Developmental Strategies
                   4.1.1    Product Launch
                   4.1.2    Agreement, Collaboration, and Partnership
                   4.1.3    Acquisition
                   4.1.4    Business Expansion
                   4.1.5    Others
          4.2    Market Share Analysis
 
    5    Global Recombinant Cell Culture Supplements Market (by Products)
          5.1    Overview
          5.2    Supplements
                   5.2.1    Recombinant Albumin (rAlbumin)
                   5.2.2    Recombinant Insulin (rInsulin)
                   5.2.3    Recombinant Epidermal Growth Factor (rEGF)
                   5.2.4    Recombinant Transferrin (rTransferrin)
                   5.2.5    Recombinant Trypsin (rTrypsin)
                   5.2.6    Recombinant Insulin-like Growth Factor (rIGF)
                   5.2.7    Recombinant Stem Cell Factor (SCF) Protein (rSCF)
                   5.2.8    Recombinant Aprotinin (rAprotinin)
                   5.2.9    Recombinant Lysozyme (rLysozyme)
                   5.2.10   Others
 
    6    Global Recombinant Cell Culture Supplements Market (by Application)
          6.1    Overview
          6.2    Stem Cell and Regenerative Medicine
          6.3    BioProduction
          6.4    Academic and Research Application
 
    7    Global Recombinant Cell Culture Supplements Market (by Region)
          7.1    Overview
          7.2    North America
                   7.2.1    The U.S.
                   7.2.2    Canada
          7.3    Europe
                   7.3.1    Germany
                   7.3.2    France
                   7.3.3    The U.K.
                   7.3.4    Italy
                   7.3.5    Spain
                   7.3.6    The Netherlands
                   7.3.7    Rest-of-Europe
          7.4    Asia-Pacific
                   7.4.1    China
                   7.4.2    Japan
                   7.4.3    S. Korea
                   7.4.4    India
                   7.4.5    Australia
                   7.4.6    Rest-of-Asia-Pacific
          7.5    Latin-America
                   7.5.1    Brazil
                   7.5.2    Mexico
                   7.5.3    Rest-of-Latin America
          7.6    Rest of the World (RoW)
                   7.6.1    Russia
                   7.6.2    Israel
                   7.6.3    Kingdom of Saudi Arabia (K.S.A.)
                   7.6.4    Others
 
    8    Company Profiles
          8.1    BBI Solutions
                   8.1.1    Company Overview
                   8.1.2    Role of BBI Solutions in the Recombinant Cell Culture Supplements Market
                   8.1.3    SWOT Analysis
          8.2    Corning Incorporated
                    8.2.1    Company Overview
                    8.2.2    Role of Corning Incorporated in Recombinant Cell Culture Supplements Market
                    8.2.3    Financials
                    8.2.4    Key Insights on Financial Health of the Company
                    8.2.5    Global Presence
                    8.2.6    SWOT Analysis
           8.3    Evercyte GmbH
                    8.3.1    Company Overview
                    8.3.2    Role of Evercyte GmbH in Recombinant Cell Culture Supplements Market
                    8.3.3    SWOT Analysis
           8.4    Gemini Bio-Products
                    8.4.1    Company Overview
                    8.4.2    Role of Gemini Bio-Products in Recombinant Cell Culture Supplements Market
                    8.4.3    SWOT Analysis
           8.5    HiMedia Laboratories
                    8.5.1    Company Overview
                    8.5.2    Role of HiMedia Laboratories in Recombinant Cell Culture Supplements Market
                    8.5.3    SWOT Analysis
           8.6    InVitria
                    8.6.1    Company Overview
                    8.6.2    Role of InVitria in the Recombinant Cell Culture Supplements Market
                    8.6.3    SWOT Analysis
           8.7    Irvine Scientific
                    8.7.1    Company Overview
                    8.7.2    Role of Irvine Scientific in Global Recombinant Cell Culture Supplements Market
                    8.7.3    SWOT Analysis
           8.8    Kingfisher Biotech, Inc.
                    8.8.1    Company Overview
                    8.8.2    Role of Kingfisher Biotech, Inc. in Recombinant Cell Culture Supplements Market
                    8.8.3    SWOT Analysis
           8.9    Lonza Group
                    8.9.1    Company Overview
                    8.9.2    Role of Lonza in Recombinant Cell Culture Supplements Market
                    8.9.3    Financials
                    8.9.4    Key Insights on Financial Health of the Company
                    8.9.5    Global Presence
                    8.9.6    SWOT Analysis
          8.10   Merck KGaA
                    8.10.1    Company Overview
                    8.10.2    Role of Merck KGaA in Recombinant Cell Culture Supplements Market
                    8.10.3    Financials
                    8.10.4    Key Insights on the Financial Health of Company
                    8.10.5    Global Presence
                    8.10.6    SWOT Analysis
          8.11   Novozymes
                    8.11.1    Company Overview
                    8.11.2    Role of Novozymes in Recombinant Cell Culture Supplements Market
                    8.11.3    Financials
                    8.11.4    Key Insights on Financial Health of the Company
                    8.11.5    Global Presence
                    8.11.6    SWOT Analysis
          8.12   PeproTech, Inc.
                    8.12.1    Company Overview
                    8.12.2    Role of PeproTech, Inc. in the Recombinant Cell Culture Supplements Market
                    8.12.3    SWOT Analysis
          8.13   Repligen Corporation
                    8.13.1    Company Overview
                    8.13.2    Role of Repligen Corporation in the Recombinant Cell Culture Supplements Market
                    8.13.3    Financials
                    8.13.4    Key Insights on Financial Health of the Company
                    8.13.5    Global Presence
                    8.13.6    SWOT Analysis
          8.14   Shenandoah Biotechnology
                    8.14.1    Company Overview
                    8.14.2    Role of Shenandoah Biotechnology in the Recombinant Cell Culture Supplements Market
                    8.14.3    SWOT Analysis
          8.15   Sino Biological Inc.
                    8.15.1    Company Overview
                    8.15.2    Role of Sino Biological Inc. in the Recombinant Cell Culture Supplements Market
                    8.15.3    SWOT Analysis
          8.16   STEMCELL Technologies Inc.
                    8.16.1    Company Overview
                    8.16.2    Role of STEMCELL Technologies Inc. in the Recombinant Cell Culture Supplements Market
                    8.16.3    SWOT Analysis
          8.17   Thermo Fisher Scientific
                    8.17.1    Company Overview
                    8.17.2    Role of Thermo Fisher Scientific in the Recombinant Cell Culture Supplements Market
                    8.17.3    Financials
                    8.17.4    Key Insights on the Financial Health of the Company
                    8.17.5    Global Presence
                    8.17.6    SWOT Analysis
          8.18   Albumedix: Snapshot
                    8.18.1    Company Overview
                    8.18.2    Product Portfolio
 
    9    Research Scope and Methodology
          9.1    Scope of the Report
          9.2    Global Recombinant Cell Culture Supplements Market Segmentation
          9.3    Research Methodology
                   9.3.1    Primary Research
                   9.3.2    Secondary Research
                   9.3.3    Key Data Points from Primary and Secondary Sources
                   9.3.4    Data Triangulation
                   9.3.5    Top-Down Approach
                   9.3.6    Bottom- Up Approach
          9.4    Assumptions and Limitations
 

List of Tables

Table 1.1    Recombinant Cell-Culture Supplements Product Offerings of Some Key Companies
Table 2.1    Impact Analysis of Market Dynamics
Table 3.1    Global Regulatory Scenario
Table 3.2    Patents Granted between January 2015 and March 2018
Table 5.1    Recombinant Albumin Products
Table 5.2    Global Recombinant Albumin Market (by Application), 2017-2028, $Million
Table 5.3    Global Recombinant Insulin Market (by Application), 2017-2028, $Million
Table 5.4    Recombinant EGF Products
Table 5.5    Global Recombinant EGF Market (by Application), 2017-2028, $Million
Table 5.6    Recombinant Transferrin Products
Table 5.7    Global Recombinant Transferrin Market (by Application), 2017-2028, $Million
Table 5.8    Recombinant Trypsin Products
Table 5.9    Global Recombinant Trypsin Market (by Application), 2017-2028, $Million
Table 5.10    Recombinant IGF-I Products
Table 5.11    Global Recombinant IGF-I Market (by Application), 2017-2028, $Million
Table 5.12    Global Recombinant SCF Supplement Products
Table 5.13    Global Recombinant SCF Market (by Application), 2017-2028, $Million
Table 5.14    Recombinant Aprotinin Products
Table 5.15    Global Recombinant Aprotinin Market (by Application), 2017-2028, $Million
Table 5.16    Recombinant Lysozyme Products
Table 5.17    Global Recombinant Lysozyme Market (by Application), 2017-2028, $Million
Table 5.18    Global Recombinant Others Supplement Products
Table 5.19    Global Recombinant Others Supplements Market (by Application), 2017-2028, $Million
Table 6.1    Companies along with Biomanufacturing Facility
Table 7.1    Global Recombinant Cell Culture Supplements Market (by Region), 2017-2028, $Million
Table 7.2    North America Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.3    Europe Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.4    Asia-Pacific Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.5    Latin America Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million
Table 7.6    RoW Recombinant Cell Culture Supplements Market (by Product), 2017-2028, $Million

List of Figures

Figure 1    Global Recombinant Cell Culture Supplements Market, 2017-2028
Figure 2    Global Recombinant Cell Culture Supplements Market (by Product), 2017 and 2028
Figure 3    Global Recombinant Cell Culture Supplements Market (by Application), 2017 and 2028
Figure 4    Global Recombinant Cell Culture Supplements Market (by Region), 2017 and 2028
Figure 1.1    Important Terminology of Cell Culture Procedure
Figure 1.2    Market for Global Recombinant Cell Culture Supplements
Figure 1.3    Global Recombinant Cell Culture Supplements Market, 2017-2028
Figure 1.4    Recombinant Cell Culture Supplements Market Segmentation
Figure 4.1    Share of Key Developmental Strategies, January 2015-July 2018
Figure 4.2    Share of Product Launch (by Company), January 2015-July 2018
Figure 4.3    Share of Agreement, Collaboration, and Partnership (by Company), January 2015-July 2018
Figure 4.4    Share of Acquisition (by Company), January 2015-July 2018
Figure 4.5    Share of Business Expansion (by Company), January 2015-July 2018
Figure 4.6    Share of Other Developments (by Company), January 2015-July 2018
Figure 4.7    Global Recombinant Cell Culture Supplements Market Share of Key Players, 2017 and 2018
Figure 4.8    Growth Share Matrix, (by Company)2018
Figure 5.1    Different Types of Cell Culture Products
Figure 5.2    Global Recombinant Cell Culture Supplements Market (by Product), 2017-2028
Figure 5.3    Global Recombinant Albumin Market, 2017-2028
Figure 5.4    Global Recombinant Insulin Market, 2017-2028
Figure 5.5    Global Recombinant EGF Market, 2017-2028
Figure 5.6    Global Recombinant Transferrin Market, 2017-2028
Figure 5.7    Features of Recombinant Trypsin
Figure 5.8    Global Recombinant Trypsin Market, 2017-2028
Figure 5.9    Global Recombinant IGF-I Market, 2017-2028
Figure 5.10    Global Recombinant SCF Market, 2017-2028
Figure 5.11    Global Recombinant Aprotinin Market, 2017-2028
Figure 5.12    Global Recombinant Lysozyme Market, 2017-2028
Figure 5.13    Global Recombinant Other Supplements Market, 2017-2028
Figure 6.1    Global Recombinant Cell Culture Supplements (by Application)
Figure 6.2    Global Recombinant Cell Culture Supplements (by Application), 2017-2028
Figure 6.3    Regenerative Medicine: Present and Future
Figure 6.4    Types of Stem Cells
Figure 6.5    Global Recombinant Cell Culture Supplements Market (by Stem Cells and Regenerative Medicine), 2017-2028
Figure 6.6    Global Recombinant Cell Culture Supplements Market (by Bioproduction), 2017-2028
Figure 6.7    Global Recombinant Cell Culture Supplements Market (by Academic and Research), 2017-2028
Figure 7.1    Global Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.2    North America Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.3    North America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.4    U.S. Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.5    Canada Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.6    Europe Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.7    Europe Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.8    Germany Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.9    France Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.10    The U.K. Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.11    Italy Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.12    Spain Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.13    The Netherlands Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.14    Rest-of-Europe Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.15    Asia-Pacific Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.16    Asia-Pacific Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.17    China Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.18    Japan Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.19    S.Korea Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.20    India Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.21    Australia Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.22    Rest-of-Asia-Pacific Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.23    Latin America Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.24    Latin America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.25    Brazil Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.26    Mexico Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.27    Rest-of-Latin-America Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.28    RoW Recombinant Cell Culture Supplements Market 2017-2028
Figure 7.29    RoW Recombinant Cell Culture Supplements Market (by Country), 2017-2028
Figure 7.30    Russia Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.31    Israel Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.32    K.S.A. Recombinant Cell Culture Supplements Market, 2017-2028
Figure 7.33    Others Recombinant Cell Culture Supplements Market, 2017-2028
Figure 8.1    Contribution of Public and Private Company Profiles
Figure 8.2    BBI Solutions: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.3    BBI Solutions: SWOT Analysis
Figure 8.4    Corning Incorporated: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.5    Corning Incorporated: Overall Financials, 2015-2017
Figure 8.6    Corning Incorporated: Revenue (by Business Segment), 2015-2017
Figure 8.7    Corning Incorporated: Revenue (by Region), 2015-2017
Figure 8.8    Corning Incorporated: R&D Expense, 2015-2017
Figure 8.9    Corning Incorporated: Revenue Forecast, 2015-2020
Figure 8.10    Corning Incorporated: Global Presence
Figure 8.11    Corning Incorporated: SWOT Analysis
Figure 8.12    Evercyte GmbH: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.13    Evercyte GmbH: SWOT Analysis
Figure 8.14    Gemini Bio-Products Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.15    Gemini Bio-Products: SWOT Analysis
Figure 8.16    HiMedia Laboratories: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.17    Himedia Laboratories: SWOT Analysis
Figure 8.18    InVitria: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.19    InVitria: SWOT Analysis
Figure 8.20    Irvine Scientific: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.21    Irvine Scientific: SWOT Analysis
Figure 8.22    Kingfisher Biotech, Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.23    Kingfisher Biotech, Inc.: SWOT Analysis
Figure 8.24    Lonza Group: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.25    Lonza Group: Overall Financials, 2015-2017
Figure 8.26    Lonza Group: Revenue (by Business Segment), 2015-2017
Figure 8.27    Lonza Group: Revenue (by Region), 2015-2017
Figure 8.28    Lonza Group: R&D Expense, 2015-2017
Figure 8.29    Lonza Group: Revenue Forecast, 2015-2020
Figure 8.30    Lonza Group: Global Presence
Figure 8.31    Lonza Group: SWOT Analysis
Figure 8.32    Merck KGaA: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.33    Merck KGaA: Overall Financials, 2015-2017
Figure 8.34    Merck KGaA: Revenue (by Business Segment), 2015-2017
Figure 8.35    Merck KGaA: Revenue (by Region), 2015-2017
Figure 8.36    Merck KGaA: R&D Expense, 2015-2017
Figure 8.37    Merck KGaA: Revenue Forecast, 2015-2020
Figure 8.38    Merck KGaA: Global Presence
Figure 8.39    Merck KGaA: SWOT Analysis
Figure 8.40    Novozymes: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.41    Novozymes: Overall Financials, 2015-2017
Figure 8.42    Novozymes: Revenue (by Business Segment), 2015-2017
Figure 8.43    Novozymes: Revenue (by Region), 2015-2017
Figure 8.44    Novozymes: R&D Expense, 2015-2017
Figure 8.45    Novozymes: Revenue Forecast, 2015-2020
Figure 8.46    Novozymes: Global Presence
Figure 8.47    Novozymes: SWOT Analysis
Figure 8.48    PeproTech, Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.49    PeproTech, Inc.: Recombinant Proteins for Cell Culture under Growth Factor and Cytokines Segment
Figure 8.50    PeproTech, Inch: SWOT Analysis
Figure 8.51    Repligen: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.52    Repligen Corporation: Overall Financials, 2015-2017
Figure 8.53    Repligen Corporation: Revenue (by Business Segment), 2015-2017
Figure 8.54    Repligen Corporation: Revenue (by Geography), 2015-2017
Figure 8.55    Repligen Corporation: R&D Expense, 2015-2017
Figure 8.56    Repligen Corporation: Revenue Forecast, 2015-2020
Figure 8.57    Repligen Corporation: Global Presence
Figure 8.58    Repligen Corporation: SWOT Analysis
Figure 8.59    Shenandoah Biotechnology Inc Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.60    Shenandoah Biotechnology Inc: SWOT Analysis
Figure 8.61    Sino Biological Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.62    Sino Biological Inc.: SWOT Analysis
Figure 8.63    STEMCELL Technologies Inc.: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.64    STEMCELL Technologies Inc.: SWOT Analysis
Figure 8.65    Thermo Fisher Scientific: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 8.66    Thermo Fisher Scientific: Overall Financials, 2015-2017
Figure 8.67    Thermo Fisher Scientific: Revenue (by Business Segment), 2015-2017
Figure 8.68    Thermo Fisher Scientific: Revenue (by Region), 2015-2017
Figure 8.69    Thermo Fisher Scientific: R&D Expense, 2015-2017
Figure 8.70    Thermo Fisher Scientific: Revenue Forecast, 2015-2020
Figure 8.71    Thermo Fisher Scientific: Global Presence
Figure 8.72    Thermo Fisher Scientific: SWOT Analysis
Figure 8.73    Albumedix: Product Offerings for Global Recombinant Cell Culture Supplements Market
Figure 9.1    Global Recombinant Cell Culture Supplements Market Segmentation
Figure 9.2    Research Methodology
Figure 9.3    Key Data Points from Primary and Secondary Sources
Figure 9.4    Data Triangulation
Figure 9.5    Top-down Approach: Global Recombinant Cell Culture Supplements Market
Figure 9.6    Bottom-up Approach: Global Recombinant Cell Culture Supplements Market
Figure 9.7    Assumptions and Limitations

With advancement in technology, techniques, and methodology, several innovative products are developed and commercialized by various industries into the market. Development in biotech and healthcare industries has led to the emergence of modern day cell culture process and techniques. Cell cultures are currently used for various applications such as bioproduction of vaccines, monoclonal antibodies, and proteins, among others. Also, research and developmental activities have increased the usage of cell culture techniques for the genetic engineering, genomics, and therapeutic research. Cell culture involves different types of products for the growth of cells such as media, sera, reagents, and supplements. Supplements help in the growth of the cell lines and culture.

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028. The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors supporting the growth of the market include increasing investment in the R&D of life sciences and biotechnology industries.

The purpose of the study is to gain a holistic view of the global recombinant cell culture supplements market in terms of various factors influencing it such as key market trends, competitive and regulatory aspects of the market, and scientific innovations into biotechnology and cell culture fields. The scope of the report is centered upon conducting a detailed study of the solutions allied with the recombinant cell culture supplements market, involving products used for different applications such as bioproduction, research and academics, and stem cell and regenerative medicine. The global recombinant cell culture supplements market is segmented into three different parts: by products, by application, and by region.

Based on applications, the market can be sub-segmented into stem cell and regenerative medicine, bioproduction, and academic and research. In 2017, stem cell and regenerative medicine was estimated to be the dominant application segment due to the increased demand for investment in the stem cell and regenerative medicine industry in developed as well as developing nations. However, the academic and research industry is expected to register the highest CAGR due to the rising investments and increased regulatory support for this industry. As recombinant supplements ensure enhanced cell viability and improved batch-to-batch consistency, they are increasingly used for research.

The recombinant cell culture supplements market can be further segmented based on the type of recombinant products into transferrin, insulin, albumin, trypsin, aprotinin, lysozyme, Insulin-like growth factor, stem cell factor, epidermal growth factor, and others. Recombinant albumin was the dominant segment in terms of revenue in 2017 while recombinant epidermal growth factor (rEGF) segment is expected to be the fastest growing segment during the forecast period from 2018 to 2028.

Geographically, the market is segmented into five distinct regions including, North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World. North America, followed by Europe, is the leading contributor of the market. Within North America, the U.S. contributed to almost 93% of the total share, and the rest of the share was occupied by Canada in 2017. Within Europe, Germany dominated the market in 2017. However, the market for the Asia-Pacific region is expected to witness the high growth rate, during the forecast period from 2018 to 2028, as compared to other regions.

The recombinant cell culture supplements market has a promising potential for the growth in the coming years with the increased usage of cell cultures and biotechnology in the modern day science. The report provides an in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each company. The key players of the market are Thermo Fisher Scientific, Hi-Media Laboratories, BBI Solutions, PeproTech, Inc., InVitria, Sino Biologicals, STEMCELL Technologies, Irvine Scientific, Merck KGaA, Corning Incoporated, Gemini Bio-Products, Novozyme A/S, and Repligen Corporation, among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields


related reports


Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors